Staphylococcus aureus in Infant Urine: Likely Pathogen
In a previously healthy infant younger than three months with fever, Staphylococcus aureus isolated from urine should be considered a true pathogen requiring treatment, not a contaminant, especially if proper collection methods were used.
Clinical Context and Significance
S. aureus is an uncommon but clinically significant cause of urinary tract infections in young infants, accounting for a small percentage of pediatric UTIs but carrying substantial implications when present 1. The key distinction between pathogen and contaminant depends critically on:
Collection Method Matters Most
- Catheterization or suprapubic aspiration: S. aureus should be considered pathogenic 2
- Bag collection: High contamination rates (12-83% false positives) make interpretation difficult; positive cultures require confirmation by catheterization 3
- Any growth from suprapubic aspiration is significant 2
Diagnostic Criteria for True UTI
According to AAP guidelines, UTI diagnosis requires both 2:
- Presence of pyuria (≥10 WBCs)
- ≥50,000 CFU/mL of a single uropathogen in appropriately collected specimens
Why S. aureus is Likely Pathogenic in This Population
Age-Specific Vulnerability
Young infants (<3 months) represent a high-risk group where S. aureus bacteriuria has distinct clinical significance 4, 1:
- Peak incidence at 7-12 days of age, particularly in male infants 4
- Community-acquired S. aureus infections (including MRSA) are increasing in previously healthy neonates 4
- 33% of patients with S. aureus bacteriuria have symptomatic UTI at initial isolation 5
Association with Serious Complications
S. aureus bacteriuria in infants is associated with 4, 5:
- Bacteremia in 13% of cases at initial presentation 5
- Risk of subsequent invasive staphylococcal infection up to 12 months later 5
- Invasive manifestations including shock, musculoskeletal infection, perinephric abscess, empyema, and death 4
Distinguishing Features Suggesting True Infection
Consider S. aureus pathogenic if:
- Fever is present (as in your case)
- Single organism isolated
- Proper collection method (catheterization/SPA)
- Colony count ≥50,000 CFU/mL 2
- Clinical symptoms of UTI present
- Pyuria documented 2
Consider contamination if:
- Mixed growth with multiple organisms 6
- Bag collection method used
- Absence of pyuria
- Low colony counts
- Asymptomatic patient
Clinical Management Algorithm
Immediate Actions
- Assess collection method: If bag specimen, confirm with catheterization 3
- Obtain blood cultures: 13% risk of concurrent bacteremia 5
- Evaluate for source control: Look for skin/soft tissue infections, maternal infection history 4
Treatment Considerations
- Initiate empiric antibiotics covering MRSA (vancomycin or alternative) given increasing community-acquired MRSA prevalence (86% of isolates in one study) 4
- Duration: 7-14 days for uncomplicated UTI 2
- Adjust based on susceptibilities once available 2
Additional Workup
For febrile infants <3 months with confirmed S. aureus UTI 2, 7:
- Renal and bladder ultrasonography to detect anatomic abnormalities
- Consider echocardiography if bacteremia confirmed (12% risk of endocarditis with S. aureus bacteremia) 8
- Monitor for metastatic infection sites 4
Common Pitfalls to Avoid
Don't dismiss as contaminant reflexively: Unlike coagulase-negative staphylococci (which are typically contaminants), S. aureus has established pathogenic potential in infant UTIs 1, 9
Don't rely on bag specimens: Positive bag cultures require confirmation; negative bag cultures can rule out UTI 3
Don't underestimate MRSA prevalence: Community-acquired MRSA (USA300 clone) predominates in neonatal infections 4
Don't miss concurrent bacteremia: Blood cultures are essential in febrile infants with S. aureus bacteriuria 5
Special Considerations
Underlying anatomical abnormalities: 84% of children with staphylococcal UTI have congenital anomalies of kidney and urinary tract (CAKUT), with 57% having vesicoureteral reflux 1. This warrants imaging even after first infection.
Gender predilection: Male infants are disproportionately affected (male-to-female ratio 3.2:1), particularly in the first two weeks of life 4, 1.